RNU6ATAC9P

Across TCGA pan-cancer cohorts, RNU6ATAC9P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC9P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RNU6ATAC9P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6ATAC9P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KICH, STAD, and COAD are the cancer types where RNU6ATAC9P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC9P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.169	.021	2	view →
STAD	All	All	+0.291	.039	1	view →
COAD	All	All	+0.208	.032	1	view →
BRCA	Female	II,III,IV	+0.128	.040	1	view →
THCA	Female	All	−0.077	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RNU6ATAC9P–KICH

Open the KICH breakdown →